Ziprasidone 2-isopropylidene; 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloro-3-(propan-2-ylidene)indolin-2-one;H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-3-(1-methylethylidene)-;5-{2-[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]ethyl}-6-chlor-3-isopropyliden-1,3-dihydro-2H-indol-2-on;5-{2-[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-3-isopropylidene-1,3-dihydro-2H-indol-2-one;5-{2-[4-(1,2-Benzothiazol-3-yl)-1-pipérazinyl]éthyl}-6-chloro-3-isopropylidène-1,3-dihydro-2H-indol-2-one;5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-3-(1-methylethylidene)-2H-indol-2-one
Ziprasidone Impurity 2 is a fully characterized chemical compound used as a reference standard of API Ziprasidone. The standard offered is compliant with regulatory guidelines. Ziprasidone Impurity 2 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 684269-12-3
